PREVENTION OF EXPERIMENTAL OCULAR HYPERTENSION WITH POLYPHLORETIN PHOSPHATE.
Cole
D F
DF
M.R.C. Ophthalmological Research Unit, Institute of Ophthalmology, University of London.
D000477:Alkylating Agents / Q000008:administration & dosage; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D004195:Disease Models, Animal; D005136:Eye Proteins / Q000378:metabolism; D007429:Intraocular Pressure / Q000187:drug effects*; D008466:Mechlorethamine / Q000008:administration & dosage; D009798:Ocular Hypertension / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D011121:Polyphloretin Phosphate / Q000008:administration & dosage*; D011448:Prostaglandin Antagonists / Q000008:administration & dosage*; D011817:Rabbits; D014065:Tonometry, Ocular; D016896:Treatment Outcome
D000477:Alkylating Agents; D005136:Eye Proteins; D011448:Prostaglandin Antagonists; D008466:Mechlorethamine; D011121:Polyphloretin Phosphate